--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About TYRA20260220P30
Biological Technology
Tyra Biosciences, Inc., was incorporated in Delaware on August 2, 2018. The company is a precision oncology company focused on developing specialized therapies to overcome tumor resistance and improve treatment outcomes for cancer patients. The company is using its proprietary SNAP platform, which is optimized to rapidly and precisely improve structural design through iterative molecular SNAPshots to generate next-generation product candidates specifically designed to address acquired resistance and provide alternative treatment options.
